I
0.405
0.01 (1.50%)
| Previous Close | 0.399 |
| Open | 0.387 |
| Volume | 123,549 |
| Avg. Volume (3M) | 563,336 |
| Market Cap | 12,580,232 |
| Price / Sales | 0.710 |
| Price / Book | 0.600 |
| 52 Weeks Range | |
| Earnings Date | 12 Mar 2025 - 17 Mar 2025 |
| Profit Margin | -115.22% |
| Operating Margin (TTM) | -86.22% |
| Diluted EPS (TTM) | -0.750 |
| Quarterly Revenue Growth (YOY) | -7.50% |
| Total Debt/Equity (MRQ) | 49.01% |
| Current Ratio (MRQ) | 0.990 |
| Operating Cash Flow (TTM) | -5.52 M |
| Return on Assets (TTM) | -13.45% |
| Return on Equity (TTM) | -64.04% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | ImmunoPrecise Antibodies Ltd. | Bullish | Bearish |
AIStockmoo Score
1.1
| Analyst Consensus | 3.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 1.13 |
|
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 12.06% |
| % Held by Institutions | 6.58% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Gradient Capital Advisors, Llc | 30 Sep 2024 | 26,808 |
| West Paces Advisors Inc. | 30 Sep 2024 | 1,665 |
| 52 Weeks Range | ||
| Median | 7.00 (1,628.40%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 11 Dec 2024 | 7.00 (1,628.40%) | Buy | 0.380 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |